Regan, 22, was diagnosed with MS when she was just 16. Whilst navigating school life and completing important exams, she started her treatment with Lemtrada – one of the strongest disease modifying drugs available for relapsing remitting MS. Here she sheds some light on her experience with the drug. She discusses what infusion clinics are like, the side effects she experienced and the ongoing monitoring after treatment.